Daniel Sjostedt

Daniel Sjostedt

ArentFox Schiff

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Pharmacy Benefit Manager Reform Remains Legislative Priority

The 2022 midterms have concluded, but the Republican underperformance is not expected to dampen Congressional enthusiasm for Pharmacy Benefit Manager (PBM) reform. The issue remains at the forefront of the healthcare pricing...more

11/23/2022  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Drug Pricing , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Healthcare , Inflation Reduction Act (IRA) , Medicare , Pharmacy Benefit Manager (PBM)
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide